Lv51
1070 积分 2024-01-17 加入
A review of treatment options employed in relapsed/refractory AML
4天前
已完结
Hematopoietic stem cell transplantation activity in China 2022–2023. The proportions of peripheral blood for stem cell source continue to grow: a report from the Chinese Blood and Marrow Transplantation Registry Group
4天前
已完结
The safety and efficacy of vosaroxin in patients with first relapsed or refractory acute myeloid leukemia - a critical review
25天前
已完结
Progress in the problem of relapsed or refractory acute myeloid leukemia
25天前
已完结
Expert consensus guidelines for the prophylaxis and management of tumor lysis syndrome in the United States: Results of a modified Delphi panel
4个月前
已完结
Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory FLT3-Mutated AML
4个月前
已完结
PI3K and Btk differentially regulate B cell antigen receptor-mediated signal transduction
1年前
已完结
PI3K and Btk differentially regulate B cell antigen receptor-mediated signal transduction
1年前
已完结
Population Pharmacokinetics of the BTK Inhibitor Acalabrutinib and its Active Metabolite in Healthy Volunteers and Patients with B-Cell Malignancies
1年前
已完结
皖公网安备34019202002308
